Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
After-Hours
In 70 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Organogenesis Holdings
Organogenesis Holdings is a leading US-based biotechnology company specializing in Regenerative Medicine products. It develops and markets innovative therapies for advanced wound care, as well as solutions for orthopedic surgery and sports medicine. The company utilizes biopharmaceuticals and tissue engineering to promote healing and improve patient outcomes.
Frequently asked questions
When will Organogenesis Holdings report its next quarterly earnings?
Organogenesis Holdings is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Organogenesis Holdings last report quarterly earnings?
Organogenesis Holdings last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.71 USD.
How does Organogenesis Holdings stock react to earnings?
Across its last 3 earnings reports, Organogenesis Holdings stock moved by ±21.4% on average the following day. The largest reaction was +44.7% on 11/06/2025; 1 of 3 reactions were positive.
How often has Organogenesis Holdings beaten expectations?
Organogenesis Holdings has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Organogenesis Holdings earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±21.4%
Avg. next-day move
+44.7%
Largest move (11/06/2025)
33.3%
Share of positive reactions
±27.9%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
-17.9%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Organogenesis Holdings
Country
🇺🇸
More Financial Information